Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Corbus Pharmaceuticals Q3 EPS $(0.07) Down From $(0.02) YoY

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.
byBenzinga Newsdesk
November 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Increase In Card Member Spending Boosts Amex Q1 Revenue, Company Eyes Steady Annual Growth

By Anusuya Lahiri
April 19, 8:30 AM
American Express Co. (NYSE: AXP) outperformed in fiscal Q1 2024, with revenues up 11% to $15.80 billion, thanks to higher net interest income and increased Card Member spending. EPS at $3.33 exceeded expectations, highlighting robust spending growth and strategic fee-based product offerings, drawing significant interest from younger consumers.

AXP